EIA
XBI icon

Edgemoor Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Edgemoor Investment Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-82,554
Closed -$11.2M – 148
2021
Q2 		$11.2M Buy
82,554
+2,356
+3% +$310K 1.04% 37
2021
Q1 		$10.9M Buy
+80,198
New +$12M 1.09% 36

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Edgemoor Investment Advisors's XBI Position: Q3 2021 in Review

Edgemoor Investment Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2021, closing a stake of 82,554 shares — an estimated $11.2M sold.

Edgemoor Investment Advisors first reported a position in XBI in Q1 2021 and held it in 2 quarters. The position peaked at $11.2M in Q2 2021. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

  • Edgemoor Investment Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2021 after selling out during the quarter.
  • Edgemoor Investment Advisors sold 82,554 State Street SPDR S&P Biotech ETF shares in Q3 2021, an estimated $11.2M.
  • Edgemoor Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and held it in 2 quarters.
  • Edgemoor Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $11.2M in Q2 2021.
  • 635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on Edgemoor Investment Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.